These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7887639)

  • 41. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group--third study on colorectal cancer.
    Ito K; Yamaguchi A; Miura K; Kato T; Baba S; Matsumoto S; Ishii M; Takagi H
    J Surg Oncol; 1996 Oct; 63(2):107-11. PubMed ID: 8888803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)].
    Tominaga T; Nomura Y; Horikoshi N; Takashima S; Kimura M; Koyama H; Kikkawa N; Toge T; Mitsuyama S; Morimoto T; Enomoto K; Wada T; Kimishima I; Niitani H;
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):983-90. PubMed ID: 16044960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
    Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
    Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
    Kubota Y; Miura T; Shuin T; Kinoshita Y; Hosaka M; Kondo I; Moriyama M; Fukushima S; Fukuoka H; Miyai K
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2301-6. PubMed ID: 1834023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II study of 5-fluorouracil, pirarubicin and low-dose consecutive administration of cisplatin for advanced and recurrent gastric cancer.
    Kikuyama S; Inada T; Miyakita M; Ogata Y
    Jpn J Clin Oncol; 1998 May; 28(5):314-7. PubMed ID: 9703858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical study of ambulatory cancer chemotherapy for recurrent breast cancer].
    Takahashi N; Nitta A; Kunii Y; Ota K
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():439-43; discussion 443-4. PubMed ID: 7802447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Steady state and disappearance of the metabolites of miproxifene phosphate in the treatment of breast cancer].
    Morimoto K; Abe O; Kinoshita H
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1565-73. PubMed ID: 9725050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Phase II study of peplomycin in breast cancer. A cooperative study. Clinical Study Group of Peplomycin for Breast Cancer in Japan].
    Kousaki G; Tominaga T; Uchino J; Hata H; Hayasaka A; Asaishi K; Kimura M; Abe O; Enomoto K; Watanabe H
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2347-51. PubMed ID: 2440387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An individual patient data meta-analysis of long supported adjuvant chemotherapy with oral carmofur in patients with curatively resected colorectal cancer.
    Sakamoto J; Kodaira S; Hamada C; Ito K; Maehara Y; Takagi H; Sugimachi K; Nakazato H; Ohashi Y;
    Oncol Rep; 2001; 8(3):697-703. PubMed ID: 11295105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].
    Suto T; Yoshida Y; Sakata Y; Ono T; Yoshida T; Yamada N; Chida N; Oohira H
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1933-8. PubMed ID: 9797816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical evaluation of estramustine phosphate in the treatment of patients with advanced breast cancers].
    Wada T; Morikawa E; Houjou T; Kadota K; Mori N; Matsunami N; Watatani M; Yasutomi M
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1901-4. PubMed ID: 2393306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Phase II study of THP (2''R)-4'-0-tetrahydropyranyladriamycin) in breast cancer].
    Abe O; Enomoto K; Tominaga T; Kasai Y; Soejima S; Kasai M; Izuo M; Yoshida M; Kubo K; Terasawa T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):578-85. PubMed ID: 3954379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)].
    Furue H; Machida T; Masaoka T; Ikeda S
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):67-75. PubMed ID: 9020948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sequential methotrexate/5-fluorouracil therapy with 5'-deoxy-5-fluorouridine against advanced gastric cancer: comparison between bolus injection and drip infusion of 5-fluorouracil administration. Hirosaki Cooperative Study Group for Cancer Chemotherapy].
    Yamada Y; Tsushima K; Sakata Y; Saito S; Ito T; Sugimoto N; Ogasawara H; Tamura Y; Moriya N; Komatsu Y
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1029-32. PubMed ID: 8210253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Weekly taxane-anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial.
    Tan QW; Luo T; Zheng H; Tian TL; He P; Chen J; Zeng HL; Lv Q
    Chin J Cancer; 2017 Mar; 36(1):27. PubMed ID: 28270181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Phase II study of 5'-DFUR treatment of the bladder and prostatic cancer].
    Ohmori H; Matsumura Y; Ochi J; Kobashi K; Akebi N; Saika T; Nanba K; Tanahashi T; Josen T; Nasu Y
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2307-14. PubMed ID: 1834024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.